anticoagulant articles & resources on Made-in-China.com

Bayer HealthCare Has Failed to Win The Backing of The US FDA's Cardiovascular

Jan 20, 2014

Bayer HealthCare has failed to win the backing of the US FDA's Cardiovascular and Renal Drugs Advisory Committee to expand the use of its oral anticoagulant Xarelto (rivaroxaban) 2.5 mg twice daily (BID) in combination with standard ...

Tags: FDA Panel, ACS Patients

Use of Drug Is Tied to a Temporary Spike in Risk of Stroke for Irregular Heartbeat People

Dec 25, 2013

Many older Americans take the blood thinner warfarin to help guard against heart trouble. However, a new study suggests use of the drug is tied to a temporary spike in the risk of stroke for people with a common heart rhythm disorder. ...

Tags: blood thinner warfarin, heart trouble, heart rhythm disorder

Seventh Sense Biosystems Obtained CE Mark Approval for Tap Blood Collection,Testing System

Nov 6, 2013

US-based Seventh Sense Biosystems has obtained CE Mark approval for its Touch Activated Phlebotomy (TAP) blood collection and testing system. Seventh Sense Biosystems' TAP painless blood collection platform allows the collection of ...

Tags: Phlebotomy Platform, CE Mark

Anti-Bed Bug Sewing Thread and Zips Is Announced by Coats Insectiban

Feb 26, 2013

World leading industrial thread and consumer textile crafts business, Coats plc announced the launch of Coats Insectiban, the world’s first anti-bed bug sewing thread and zips. Coats have developed an anti-bed bug chemical ...

Tags: textile crafts business, Coats Insectiban

Bristol-Myers Squibb and Pfizer Have Announced The US FDA's Approval for Eliquis

Jan 4, 2013

Bristol-Myers Squibb and Pfizer have announced the US FDA's approval for Eliquis (apixaban), used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. In 2007, Pfizer and Bristol-Myers ...

Tags: US, FDA, Eliquis, patients, nonvalvular atrial fibrillation

Bristol-Myers Squibb and Pfizer Announced The Approval of Eliquis

Dec 28, 2012

Bristol-Myers Squibb and Pfizer have announced the approval of Eliquis (apixaban) anticoagulant for the prevention of ischemic stroke and systemic embolism in patients suffering from nonvalvular atrial fibrillation (NVAF) in Japan. The ...

Tags: Japan, approval, anticoagulant, subanalysis

Boston Scientific Completes Enrolling Patients in Its Prevail Confirmatory Study

Dec 17, 2012

Boston Scientific, a provider of cardiovascular implants, has completed enrolling patients in its Prevail confirmatory study. The CE-marked self-expanding nitinol frame Watchman device, placed in the left atrial appendage (LAA) via the ...

Tags: Boston Scientific, cardiovascular implants, Prevail confirmatory study

Boston Scientific Receives CE Mark Approval for Expanded Use

Dec 17, 2012

Boston Scientific has received CE mark approval for an expanded indication of Watchman Left Atrial Appendage (LAA) Closure device, designed to capture any clots that may form in the appendage. The Watchman device also reduces the risk of ...

Tags: CE mark approval, Watchman Device

Janssen Research & Development Has Submitted Supplemental New Drug Applications

Dec 5, 2012

Janssen Research & Development has submitted supplemental New Drug Applications (sNDAs) to the US Food and Drug Administration (FDA) for the use of Xarelto (rivaroxaban), an oral anticoagulant. Janssen said the drug is used to treat ...

Tags: Xarelto, rivaroxaban, DVT, pulmonary embolism, VTE

Janssen Research & Development Has Submitted a Supplemental New Drug Application

Dec 3, 2012

Janssen Research & Development has submitted a supplemental new drug application (sNDA) with FDA, seeking approval to use Xarelto (rivaroxaban), an oral anticoagulant, to reduce the risk of stent thrombosis in patients with acute coronary ...

Tags: Xarelto, new drug application, pharmaceutical product

The European Commission Has Cleared an Oral Anticoagulant, Eliquis

Nov 28, 2012

The European Commission has cleared an oral anticoagulant, Eliquis, developed by Bristol-Myers Squibb (BMS) and Pfizer. Eliquis 5mg, trade name of apixaban in Europe, is indicated as a twice-daily drug for preventing strokes and systemic ...

Tags: BMS-Pfizer Oral Anticoagulant, oral anticoagulant, Eliquis, apixaban

Bayer Oral Anticoagulant Xarelto Has Gained Positive CDR Recommendation

Nov 28, 2012

Bayer oral anticoagulant Xarelto has gained positive common drug review (CDR) recommendation from the Canadian Agency for Drugs and Technologies in Health for the prevention of stroke and systemic embolism in atrial fibrillation (AF) ...

Tags: Bayer oral anticoagulant Xarelto, CDR Recommendation, Stroke Prevention

FDA Approve Fenwal for Cell Separation Devices New Indications

Oct 8, 2012

The US Food and Drug Administration (FDA) has granted clearance to Fenwal for two new indications for collection of plasma products on its cell separation devices, thus providing blood centers more flexibility to collect plasma on mobile ...

Tags: cell separation devices, collection of plasma products, plasma products

The Platelet Rich Plasma Facilitates Physicians to Improve Surgical Outcomes

Jun 5, 2012

The US Food and Drug Administration (FDA) has cleared Arteriocyte Medical Systems' 50cc volume of Anticoagulant Citrate Dextrose Solution, USP (ACD-A) for use with its Magellan Platelet Separation system. The Magellan system utilizes ...

Tags: FDA, Anticoagulant Citrate Dextrose Solution, clinical technology

anticoagulant

Related Products